QQQ   439.10 (+0.88%)
AAPL   182.07 (+0.36%)
MSFT   409.68 (+0.48%)
META   489.87 (+1.21%)
GOOGL   138.47 (+1.53%)
AMZN   175.13 (+1.14%)
TSLA   203.40 (+0.67%)
NVDA   795.74 (+2.46%)
NIO   5.76 (+6.08%)
AMD   183.59 (+3.99%)
BABA   74.77 (+0.24%)
T   17.07 (+0.65%)
F   12.43 (+1.06%)
MU   89.17 (-0.60%)
CGC   3.38 (+0.60%)
GE   156.02 (+0.26%)
DIS   112.28 (+1.34%)
AMC   4.61 (-7.62%)
PFE   26.98 (-0.22%)
PYPL   61.75 (+2.49%)
XOM   104.93 (+0.58%)
QQQ   439.10 (+0.88%)
AAPL   182.07 (+0.36%)
MSFT   409.68 (+0.48%)
META   489.87 (+1.21%)
GOOGL   138.47 (+1.53%)
AMZN   175.13 (+1.14%)
TSLA   203.40 (+0.67%)
NVDA   795.74 (+2.46%)
NIO   5.76 (+6.08%)
AMD   183.59 (+3.99%)
BABA   74.77 (+0.24%)
T   17.07 (+0.65%)
F   12.43 (+1.06%)
MU   89.17 (-0.60%)
CGC   3.38 (+0.60%)
GE   156.02 (+0.26%)
DIS   112.28 (+1.34%)
AMC   4.61 (-7.62%)
PFE   26.98 (-0.22%)
PYPL   61.75 (+2.49%)
XOM   104.93 (+0.58%)
QQQ   439.10 (+0.88%)
AAPL   182.07 (+0.36%)
MSFT   409.68 (+0.48%)
META   489.87 (+1.21%)
GOOGL   138.47 (+1.53%)
AMZN   175.13 (+1.14%)
TSLA   203.40 (+0.67%)
NVDA   795.74 (+2.46%)
NIO   5.76 (+6.08%)
AMD   183.59 (+3.99%)
BABA   74.77 (+0.24%)
T   17.07 (+0.65%)
F   12.43 (+1.06%)
MU   89.17 (-0.60%)
CGC   3.38 (+0.60%)
GE   156.02 (+0.26%)
DIS   112.28 (+1.34%)
AMC   4.61 (-7.62%)
PFE   26.98 (-0.22%)
PYPL   61.75 (+2.49%)
XOM   104.93 (+0.58%)
QQQ   439.10 (+0.88%)
AAPL   182.07 (+0.36%)
MSFT   409.68 (+0.48%)
META   489.87 (+1.21%)
GOOGL   138.47 (+1.53%)
AMZN   175.13 (+1.14%)
TSLA   203.40 (+0.67%)
NVDA   795.74 (+2.46%)
NIO   5.76 (+6.08%)
AMD   183.59 (+3.99%)
BABA   74.77 (+0.24%)
T   17.07 (+0.65%)
F   12.43 (+1.06%)
MU   89.17 (-0.60%)
CGC   3.38 (+0.60%)
GE   156.02 (+0.26%)
DIS   112.28 (+1.34%)
AMC   4.61 (-7.62%)
PFE   26.98 (-0.22%)
PYPL   61.75 (+2.49%)
XOM   104.93 (+0.58%)
NASDAQ:SPNS

Sapiens International (SPNS) Stock Price, News & Analysis

$30.88
+0.56 (+1.85%)
(As of 10:03 AM ET)
Today's Range
$30.76
$30.93
50-Day Range
$26.57
$30.98
52-Week Range
$18.86
$31.39
Volume
17,682 shs
Average Volume
100,861 shs
Market Capitalization
$1.70 billion
P/E Ratio
27.57
Dividend Yield
1.68%
Price Target
$34.33

Sapiens International MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
11.2% Upside
$34.33 Price Target
Short Interest
Healthy
0.57% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.95mentions of Sapiens International in the last 14 days
Based on 13 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.76%
From $1.37 to $1.49 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.17 out of 5 stars

Computer And Technology Sector

276th out of 597 stocks

Prepackaged Software Industry

86th out of 207 stocks


SPNS stock logo

About Sapiens International Stock (NASDAQ:SPNS)

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields. It offers IDITSuite, an AI powered, end-to-end insurance software; DigitalSuite, a cloud-native, future-proof digital engagement platform; IDITGo, a pre-configured, data-enriched insurance launch and accelerator platform solutions; consultancy services for property and casualty commercial lines; and Tia Enterprise solution for customer engagement. The company also provides CoreSuite, an end-to-end cloud and digital PAS for individual and group products across life, health, wealth, and pensions; CustomerConnect, a dynamic self-service and persona-based portal to engage with insureds; AgentConnect, a portal for agents and brokers to focus on sales enablement, customer retention, and increasing customer value; and ReinsuranceMaster, a reinsurance automation software that provides insurers full financial control and flexibility over their entire reinsurance process. The company was founded in 1982 and is headquartered in Holon, Israel.

SPNS Stock Price History

SPNS Stock News Headlines

Game-Changing Cancer Tech Nears FDA Completion
In the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it.
Game-Changing Cancer Tech Nears FDA Completion
In the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it.
Sapiens (SPNS) Q4 Earnings and Revenues Surpass Estimates
Recap: Sapiens Intl Corp Q4 Earnings
Sapiens Reports Fourth Quarter 2023 Financial Results
Sapiens Reports Fourth Quarter 2023 Financial Results
Sapiens International Corp. N.V.
Sapiens: Double-Lever Margin Lift
See More Headlines
Receive SPNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sapiens International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
2/29/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Application Software
Current Symbol
NASDAQ:SPNS
CUSIP
N7716A15
Employees
4,754
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$34.33
High Stock Price Target
$38.00
Low Stock Price Target
$30.00
Potential Upside/Downside
+13.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$62.44 million
Pretax Margin
14.99%

Debt

Sales & Book Value

Annual Sales
$514.58 million
Cash Flow
$1.66 per share
Book Value
$8.16 per share

Miscellaneous

Free Float
46,318,000
Market Cap
$1.67 billion
Optionable
Optionable
Beta
1.16
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Roni Al-Dor (Age 63)
    President, CEO & Director
  • Mr. Roni Giladi (Age 53)
    Chief Financial Officer
  • Mr. Ilan Buganim
    Chief Technology & Information Officer
  • Ms. Yaffa Cohen-Ifrah
    Chief Marketing Officer & Head of Investor Relations
  • Ms. Osnat Segev-Harel (Age 62)
    Head of Corporate Development
  • Mr. Rodrigo Rueda
    Sales Director
  • Ms. Noa Brummer
    Chief Human Resources Officer
  • Mr. Raj Ghuman
    Senior Vice President of Business Development – EMEA & APAC
  • Ms. Hagit Ashkenazi
    Executive VP & Head of Professional Services
  • Mr. Gary J. Sherne
    EVP & Chief Revenue Officer of North America














SPNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Sapiens International stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sapiens International in the last twelve months. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SPNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SPNS, but not buy additional shares or sell existing shares.
View SPNS analyst ratings
or view top-rated stocks.

What is Sapiens International's stock price target for 2024?

3 brokerages have issued twelve-month target prices for Sapiens International's stock. Their SPNS share price targets range from $30.00 to $38.00. On average, they predict the company's share price to reach $34.33 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price.
View analysts price targets for SPNS
or view top-rated stocks among Wall Street analysts.

How have SPNS shares performed in 2024?

Sapiens International's stock was trading at $28.94 at the beginning of the year. Since then, SPNS stock has increased by 6.7% and is now trading at $30.88.
View the best growth stocks for 2024 here
.

When is Sapiens International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our SPNS earnings forecast
.

How were Sapiens International's earnings last quarter?

Sapiens International Co. (NASDAQ:SPNS) posted its quarterly earnings results on Tuesday, February, 20th. The technology company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.34 by $0.02. The technology company earned $130.86 million during the quarter, compared to analyst estimates of $130.85 million. Sapiens International had a net margin of 12.14% and a trailing twelve-month return on equity of 16.92%. The company's quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the business earned $0.31 earnings per share.

How often does Sapiens International pay dividends? What is the dividend yield for Sapiens International?

Sapiens International declared a Semi-Annual dividend on Wednesday, August 2nd. Investors of record on Wednesday, August 16th will be given a dividend of $0.26 per share on Wednesday, August 30th. This represents a yield of 1.6%. The ex-dividend date of this dividend is Tuesday, August 15th. This is a boost from the stock's previous Semi-Annual dividend of $0.23.
Read our dividend analysis for SPNS
.

Is Sapiens International a good dividend stock?

Sapiens International (NASDAQ:SPNS) pays an annual dividend of $0.52 per share and currently has a dividend yield of 1.72%. The dividend payout ratio is 46.43%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SPNS will have a dividend payout ratio of 34.90% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SPNS.

What ETFs hold Sapiens International's stock?
What guidance has Sapiens International issued on next quarter's earnings?

Sapiens International updated its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $550.0 million-$555.0 million, compared to the consensus revenue estimate of $550.6 million.

What is Roni Al-Dor's approval rating as Sapiens International's CEO?

152 employees have rated Sapiens International Chief Executive Officer Roni Al-Dor on Glassdoor.com. Roni Al-Dor has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Sapiens International own?
Who are Sapiens International's major shareholders?

Sapiens International's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.51%), Dimensional Fund Advisors LP (1.83%), Price T Rowe Associates Inc. MD (1.64%), Price T Rowe Associates Inc. MD (1.64%), Nuveen Asset Management LLC (0.85%) and Royal Bank of Canada (0.48%).

How do I buy shares of Sapiens International?

Shares of SPNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SPNS) was last updated on 2/29/2024 by MarketBeat.com Staff